These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6470094)

  • 41. Comparative in vitro activities of 13 antimicrobial agents against Morganella-Proteus-Providencia group bacteria from urinary tract infections.
    Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Ravagnan G
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1644-7. PubMed ID: 3435110
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Urinary tract infection trends in Latin American hospitals: report from the SENTRY antimicrobial surveillance program (1997-2000).
    Gales AC; Sader HS; Jones RN;
    Diagn Microbiol Infect Dis; 2002 Nov; 44(3):289-99. PubMed ID: 12493177
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An assessment of the Sensititre method for determining minimum inhibitory and bactericidal concentrations.
    Pykett AH
    J Clin Pathol; 1978 Jun; 31(6):536-8. PubMed ID: 670408
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Different antimicrobial susceptibility testing methods to detect ertapenem resistance in Enterobacteriaceae: VITEK2, MicroScan, Etest, disk diffusion, and broth microdilution.
    Lee M; Chung HS
    J Microbiol Methods; 2015 May; 112():87-91. PubMed ID: 25794901
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Sensitivity to some antibacterial agents, of the microbial flora isolated from patients with infections of the urinary tract in the years 1964-1967].
    Diana L; Romano M; Perin G
    Ig Mod; 1968; 61(5):292-315. PubMed ID: 4889607
    [No Abstract]   [Full Text] [Related]  

  • 46. Studies on cinoxacin. 1. In vitro activity of cinoxacin, as compared to nalidixic acid, against urinary tract pathogens.
    Mårdh PA; Collen S; Andersson KE
    J Antimicrob Chemother; 1977 Sep; 3(5):411-6. PubMed ID: 903323
    [No Abstract]   [Full Text] [Related]  

  • 47. Antibacterial susceptibility testing by the dip-slide technique: a methodological evaluation.
    Dornbusch K; Nord CE; Olsson B; Thunell S
    Chemotherapy; 1976; 22(3-4):190-202. PubMed ID: 1269289
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Antibacterial action of septrin in vitro against microorganisms causing urinary tract infections in comparison with their sensitivity to other chemotherapeutic and antibiotic drugs].
    Ganczarski A; Augustyniak G; Brauner G; Prelich A; Stapor K
    Przegl Lek; 1973; 30(3):303-7. PubMed ID: 4633373
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparison of the Phoenix automated system, the Etest method and broth microdilution in determining temocillin susceptibility of Enterobacteriaceae.
    Patel TA; Dilley R; Williams A; Vanstone GL; Balakrishnan I
    J Antimicrob Chemother; 2013 Jul; 68(7):1685-6. PubMed ID: 23416956
    [No Abstract]   [Full Text] [Related]  

  • 50. Multicenter laboratory evaluation of the bioMérieux Vitek antimicrobial susceptibility testing system with 11 antimicrobial agents versus members of the family Enterobacteriaceae and Pseudomonas aeruginosa.
    Doern GV; Brueggemann AB; Perla R; Daly J; Halkias D; Jones RN; Saubolle MA
    J Clin Microbiol; 1997 Aug; 35(8):2115-9. PubMed ID: 9230393
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Therapy of urinary tract infections: striking Gram-negative germs. Changes in the bacterial spectrum and resistance in a group of patients over an 18-year period].
    Gussmann S
    Fortschr Med; 1983 Sep; 101(36):1626-9. PubMed ID: 6629294
    [No Abstract]   [Full Text] [Related]  

  • 52. Rapid MIC testing with the sensititre autoreader.
    Staneck JL; Allen SD; Harris EE; Tilton RC
    J Clin Microbiol; 1988 Jan; 26(1):1-7. PubMed ID: 3343301
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antimicrobial susceptibilities of aerobic and facultative gram-negative bacilli isolated from Chinese patients with urinary tract infections between 2010 and 2014.
    Yang Q; Zhang H; Wang Y; Xu Z; Zhang G; Chen X; Xu Y; Cao B; Kong H; Ni Y; Yu Y; Sun Z; Hu B; Huang W; Wang Y; Wu A; Feng X; Liao K; Luo Y; Hu Z; Chu Y; Lu J; Su J; Gui B; Duan Q; Zhang S; Shao H; Badal RE
    BMC Infect Dis; 2017 Mar; 17(1):192. PubMed ID: 28264656
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multicenter Evaluation of the Accelerate PhenoTest BC Kit for Rapid Identification and Phenotypic Antimicrobial Susceptibility Testing Using Morphokinetic Cellular Analysis.
    Pancholi P; Carroll KC; Buchan BW; Chan RC; Dhiman N; Ford B; Granato PA; Harrington AT; Hernandez DR; Humphries RM; Jindra MR; Ledeboer NA; Miller SA; Mochon AB; Morgan MA; Patel R; Schreckenberger PC; Stamper PD; Simner PJ; Tucci NE; Zimmerman C; Wolk DM
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29305546
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Modified microdilution susceptibility test for staphylococci, streptococci and Haemophilus spp.
    Fass RJ; Helsel VL
    Eur J Clin Microbiol; 1984 Aug; 3(4):318-9. PubMed ID: 6489321
    [No Abstract]   [Full Text] [Related]  

  • 56. In vitro synergy of cefazolin-tobramycin against gram-positive bacteria.
    Collins RF; Edwards LD
    J Antimicrob Chemother; 1980 May; 6(3):323-31. PubMed ID: 7400067
    [No Abstract]   [Full Text] [Related]  

  • 57. Results of an interlaboratory test on antimicrobial susceptibility testing of bacteria from animals by broth microdilution.
    Wallmann J; Böttner A; Goossens L; Hafez HM; Hartmann K; Kaspar H; Kehrenberg C; Kietzmann M; Klarmann D; Klein G; Krabisch P; Kühn T; Luhofer G; Richter A; Schulz B; Schwarz S; Sigge C; Traeder W; Waldmann KH; Werckenthin C; ; Zschiesche E
    Int J Antimicrob Agents; 2006 Jun; 27(6):482-90. PubMed ID: 16697559
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification and antimicrobial susceptibility testing of Gram-positive and Gram-negative bacteria from positive blood cultures using the Accelerate Pheno™ system.
    Ullberg M; Özenci V
    Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):139-149. PubMed ID: 31641972
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Comparative characteristics of the antimicrobial effect of antibiotics and their combinations on bacteria isolated from patients with chronic suppurative sinusitis].
    Tarasov DI; Gorshteĭn RM; Vasina TA
    Vestn Otorinolaringol; 1985; (6):33-6. PubMed ID: 4090157
    [No Abstract]   [Full Text] [Related]  

  • 60. In vitro susceptibilities of aerobic and facultative gram-negative bacilli isolated from patients with intra-abdominal infections worldwide: the 2002 Study for Monitoring Antimicrobial Resistance Trends (SMART).
    Chow JW; Satishchandran V; Snyder TA; Harvey CM; Friedland IR; Dinubile MJ
    Surg Infect (Larchmt); 2005; 6(4):439-48. PubMed ID: 16433608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.